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Abbreviations: 3meA, 3-methyladenine; Aag/Mpg, alkyladenine glycosylase; AP abasic; Atm, 
ataxia telangiectasia mutated; BER, base excision repair; BM, bone marrow; CR, calorie 
restriction; Exo1, exonuclease 1; Mgmt, O
6
MeG DNA methyltransferase; MMR, mismatch 
repair; MMS, methyl methanesulfonate; MNU, N-methyl-N-nitrosourea; Msh6, MutS homolog 
6; NER, nucleotide excision repair; O
6
MeG, O
6
-methylguanine RONS, reactive oxygen nitrogen 
species, WT, wildtype. 
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ABSTRACT 
 
The accumulation of DNA damage is thought to contribute to the physiological decay associated 
with the aging process. Here, we report the results of a large-scale study examining longevity in 
various mouse models defective in the repair of DNA alkylation damage, or defective in the 
DNA damage response.  We find that the repair of spontaneous DNA damage by alkyladenine 
DNA glycosylase (Aag/Mpg)-initiated base excision repair and O
6
-methylguanine DNA 
methyltransferase (Mgmt)-mediated direct reversal contributes to maximum life span in the 
laboratory mouse.  We also uncovered important genetic interactions between Aag, which 
excises a wide variety of damaged DNA bases, and the DNA damage sensor and signaling 
protein, Atm. We show that Atm plays a role in mediating survival in the face of both 
spontaneous and induced DNA damage, and that Aag deficiency not only promotes overall 
survival, but also alters the tumor spectrum in Atm
-/-
 mice.  Further, the reversal of spontaneous 
alkylation damage by Mgmt interacts with the DNA mismatch repair pathway to modulate 
survival and tumor spectrum.  Since these aging studies were performed without treatment with 
DNA damaging agents, our results indicate that the DNA damage that is generated endogenously 
accumulates with age, and that DNA alkylation repair proteins play a role in influencing 
longevity.  
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1  INTRODUCTION 
 
Aging can be thought of as a progressive decline in function at the cellular, tissue, and 
organismal level, possibly resulting from cumulative damage to important biomolecules [1].  The 
reasons why we age and modulators of the aging process have been intensively studied for 
decades (reviewed in [1]).  One predominant but recently contested school of thought [2, 3], is 
described in the mitochondrial free radical theory of aging.  In 1956, Harman first proposed that 
mitochondrially-generated reactive oxygen and nitrogen species (RONS), along with other 
harmful environmental physical and chemical agents, result in accumulating damage in 
numerous biomolecules critical for proper cell function [4].  Genetic experiments in various 
model organisms have pinpointed a variety of genes and pathways that influence how an 
organism ages (reviewed in [5-8]); however, it has become clear that additional random events 
also play an important role in the determination of longevity.   In fact, the accumulation of 
unrepaired DNA damage causing decreased genomic integrity, has long been proposed as a 
major source of stochastic changes that can influence aging (reviewed in [9, 10]).  Accordingly, 
animals with genetic deficiencies in double-strand-break repair or telomere maintenance have 
much shorter lifespans than wild-type (WT) mice [11, 12].  Further demonstrating the 
importance of unrepaired DNA damage in aging, mice or patients carrying mutations in the 
transcription-coupled branch of nucleotide excision repair (NER) suffer from a premature onset 
of aging-related symptoms and consequent shortening of lifespan, but interestingly, with the  
exception of skin cancers, the decreased longevity occurs in the absence of increased cancer 
development (reviewed in [13, 14][10]).   
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Inactivating mutations that disrupt the maintenance of genome stability can decrease longevity 
through either increasing cancer predisposition or causing more general premature aging and 
progeroid-like characteristics (reviewed in [10, 15, 16]).  Indeed, multiple important DNA 
damage response proteins were originally identified through the investigation of cancer-prone 
patients.  Cancer-prone Li-Fraumeni and ataxia telangiectasia (AT) patients exhibit germline 
mutations in two important DNA damage response proteins, namely p53 and ataxia 
telangiectasia mutated (ATM), respectively [17].  p53 (i.e., Trp53) is a stress sensor and 
transcription factor responsible for inducing cell cycle checkpoints, apoptosis or senescence upon 
exposure to DNA damage, hypoxia, and oncogene activation among other stimuli; p53 was 
originally identified as a tumor suppressor and is known as the “guardian” of the genome [17-
19].  p53 also appears to have additional roles in modulating aging, independent of its role in 
tumor suppression, presumably related to its role in cellular senescence [17, 20].  ATM, an 
integral DNA damage signaling protein, is a serine/threonine protein kinase that is activated in 
response to double-strand DNA breaks; ATM’s activation initiates important signaling pathways, 
some of which involve p53, responsible for cell cycle checkpoint activation, apoptosis and DNA 
repair (reviewed in [21]).  
 
DNA is exposed to a wide-range of damaging agents, not only from exogenous, but also from 
endogenous sources. DNA base alkylation is one common consequence of multiple endogenous 
metabolic processes (reviewed in [22]).   For example, alkylation can occur as a consequence of 
the non-enzymatic transfer of methyl groups to DNA from the universal methyl donor, 
S‐adenosylmethionine.  Additionally, RONS, inevitable byproducts of aerobic metabolism and 
also an important component of the innate immune response, are highly reactive chemical 
species that produce numerous types of DNA damage.  Furthermore, RONS can indirectly 
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induce alkylation DNA damage as a result of lipid peroxidation reactions that generate reactive 
alkylating agents that react to produce etheno (ε) and other DNA base adducts [23-27].  Livers of 
aged animals exhibit an accumulation of ε adducts, specifically εA, suggesting a possible role for 
these lipid peroxidation reactions in aging organisms [28].  DNA base lesions are also increased 
under conditions of chronic inflammation, and are believed to contribute to the increased risk of 
carcinogenesis observed in patients with chronic inflammation [29-32].  Therefore, various types 
of alkylation damage arise in cells as a function of normal metabolic functions, and the role of 
such endogenous DNA damage in influencing longevity has yet to be determined.   
 
The pathways primarily responsible for the repair of alkylated DNA base lesions are base 
excision repair (BER) and direct reversal (reviewed in [33].)  BER is initiated when a damaged 
DNA base is recognized and excised by a DNA glycosylase; alkyladenine DNA glycosylase 
(Aag, a.k.a Mpg) recognizes numerous alkylated DNA base lesions, including 3-methyladenine 
(3meA) and 7-methylguanine (7meG) in mammals.  Aag also recognizes many lesions induced 
by RONS and lipid peroxidation products including hypoxanthine and εA respectively [34-36].  
Other alkylated DNA bases are subject to direct reversal repair, either by oxidative 
demethylation catalyzed by the AlkB homolog (Alkbh) family of proteins (reviewed in [33]), or 
by the efficient transfer of the unwanted methyl group on O
6
-methylguanine (O
6
MeG) lesions to 
a cysteine residue in the O
6
MeG DNA methyltransferase (Mgmt) in a suicide reaction [37].  
Unrepaired O
6
MeG lesions pair with thymine during replication.  The mismatch repair (MMR) 
pathway recognizes O
6
MeG:thymine (O
6
MeG:T) mismatches and subsequent MMR processing 
plays an essential role in alkylation-induced cytotoxicity.  MutS, a heterodimer of Msh2 and 
Msh6 MMR proteins, recognizes O
6
MeG:T mispairs, and this recognition is required for the 
induction of apoptosis [38-40].  The MMR pathway then engages in futile cycles of Exonuclease 
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1 (Exo1)-mediated excision and DNA polymerase resynthesis at O
6
MeG:T mismatches, with 
excision and reinsertion of the thymine opposite O
6
MeG; this results in persistent strand breaks 
that ultimately culminate in the formation of double-strand DNA breaks at collapsed replication 
forks (reviewed in [33, 37]).  This alkylation hypersensitivity observed in the absence of Mgmt is 
dependent on the presence of a functional MMR pathway [40-43].     
The contribution of endogenous DNA alkylation damage to longevity has not been rigorously 
examined.  It is well-documented that Mgmt expression protects mice from tumors induced by 
treatment with exogenous alkylating agents and therefore prolongs survival following treatment 
with alkylating agents [44-47].  Intriguingly, transgenic C3HeB/FeJ male mice overexpressing 
Mgmt are protected against spontaneous hepatocellular carcinomas in a susceptible mouse strain 
[48], suggesting a role for O
6
MeG lesions in spontaneous tumors in a predisposed background 
and perhaps enhanced overall survival.  It has been more challenging to investigate the role for 
BER in longevity due to the embryonic lethality observed upon deletion of many BER proteins 
[49-51].  However, studies in heterozygous mice have provided insight into the importance of 
BER proteins in modulating survival; for example, Polb
+/-
 mice exhibit an acceleration in the 
age-dependent mortality rate as well as increased tumorigenesis [52].   Finally, we and others 
have illustrated the importance of Mgmt- and Aag-initiated DNA repair in chronic inflammation-
associated cancer, a frequent aging-associated phenomenon; Aag
-/- 
and Mgmt
-/-
 mice are more 
susceptible to chronic inflammation-associated colon carcinogenesis [31, 32, 53, 54].  However, 
the contribution of Aag and Mgmt to overall longevity was, heretofore, not specifically 
investigated.   
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Here we exploit mouse model systems to determine whether DNA alkylation repair proteins 
acting on spontaneous DNA damage contribute to aging and longevity. We performed a large-
scale study to assess whether two major DNA alkylation repair pathways, namely Aag-initiated 
BER and Mgmt-mediated direct reversal, promote longevity.  Supplemental Table 1 lists the 
mouse genotypes used in this study.   We compared the longevity of Aag
-/-
, Mgmt
-/-
 and Aag
-/-
/Mgmt
-/-
 mice with that of WT mice.  We also investigated putative genetic interactions that Aag 
and Mgmt might have with the DNA damage response pathways controlled by p53 and Atm.  
Finally, because the MMR pathway is an important modulator of cellular responses to O
6
MeG, 
we investigated possible genetic interactions between Mgmt and MMR by examining Mgmt 
-/-
/Msh6 
-/-
 and Mgmt 
-/-
/Exo1 
-/-
 mice.  Together, our comprehensive study illustrates that the repair 
of spontaneous DNA base damage, likely to be primarily alkylation damage, influences the 
longevity of mice, and provides information about potential interactions between DNA 
alkylation repair proteins and downstream DNA damage response mediators.   
 
2 RESULTS 
 
 
2.1  Deficiency in alkylation repair alters long-term survival 
Given that the endogenous generation of DNA damage is ubiquitous and continuous, we 
determined whether repair of spontaneous DNA base damage, primarily alkylation damage, 
contributes to longevity in mammals by assessing the long-term survival of mice deficient in 
genes for the repair of alkylated DNA bases, i.e, Aag
-/- 
and Mgmt
-/-
 mice.  Large cohorts of WT, 
Aag
-/-
, Mgmt
-/- and Aag-/-/Mgmt-/- mice were established and carefully monitored for up to three 
years.  Unlike mice deficient in NER [10, 14], none of the genotypes exhibited any signs of 
premature aging.  As mice became moribund, survival and histological data were collected.   
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Compared to WT mice, Aag
-/- 
and Mgmt
-/-
 mice exhibit a trend toward decreased longevity, 
which did not reach statistical significance (Figure 1A).  However, the Aag
-/-
/Mgmt
-/-
 animals 
display a significantly shorter life-span compared to WT (p=0.04); the median survival of Aag
-/-
/Mgmt
-/-
 mice was 89.5 weeks, more than 15 weeks shorter than the median survival observed in 
WT mice (Figure 1A).  These data indicate the importance of repairing spontaneous DNA base 
lesions for attaining maximum longevity. 
 
The large-scale aging studies included detailed histopathological examination to identify 
pathological features in the mice, including classification of any tumors, to determine whether 
modulating DNA repair altered tumor incidence and/or tumor spectrum.  In our study, the most 
prevalent tumor type in WT, Aag
-/-
, Mgmt
-/-
, and Aag
-/-
 /Mgmt
-/-
 mice was histiocytic sarcoma, a 
macrophage neoplasm and the most common tumor classification in the C57Bl/6 strain [55]. We 
find that the absence of either Aag or Mgmt activity (or both) did not significantly alter the 
tumor incidence or spectrum when compared to the WT mice (Figure 1B); in other words, 
although the repair-deficient mice succumb earlier than WT, the spectrum of disease and cause 
of death remains similar.  
 
2.1  Influence of DNA damage response proteins on responses to endogenous DNA 
alkylation damage 
The p53 and Atm proteins are important stress mediators that respond to DNA damage.  Mice 
deficient in these proteins exhibit drastically reduced longevity, developing thymic lymphoma 
within the first year of life [56, 57].  We sought to determine whether accumulating unrepaired 
spontaneous DNA base damage (again, primarily alkylation damage) may contribute to 
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lymphomagenesis and diminished longevity in Atm
-/-
 and p53
-/-
 mice.  Although it is well 
established that Atm
-/-
 mice exhibit significantly shortened life spans [56, 58], detailed longevity, 
studies have not been reported for the C57Bl/6 strain background.  Figure 2A shows Kaplan-
Meier survival curves for Atm
-/-
 mice, both alone and in combination with the Aag or Mgmt null 
alleles.  Atm
-/-
,
 
Aag
-/-
/Atm
-/-
, and Mgmt
-/-
/Atm
-/-
 mice all exhibit decreased survival when 
compared to the WT mice (all pair-wise comparisons to wild type, p<0.0001).  However, in 
contrast to previous studies in mixed background mice, we find that Atm
-/-
 C57Bl/6 mice survive 
significantly longer than Atm
-/-
 mixed background mice [56, 58].  In fact, in our aging study, 
20% of Atm
-/-
 C57Bl/6 mice survive longer than one year (Figure 2A), whereas most Atm
-/-
 mice 
on a mixed background succumbed to thymic lymphoma by 4.5 months [56, 58].  We find that 
the addition of the Mgmt null allele does not significantly change the survival of Atm
-/-
 animals 
(p=0.3423), suggesting that endogenously formed O
6
MeG lesions are not determinants of 
survival in Atm
-/-
 mice. Surprisingly, Aag
-/-
/Atm
-/- 
C57Bl/6 mice live significantly longer than 
Atm 
-/- 
C57Bl/6 mice (pair-wise comparison between Atm
-/-
 and Aag
-/-
/Atm
-/-
, p=0.0193) (Figure 
2A).  These results indicate that, in contrast to Aag-mediated repair of endogenous DNA base 
damage extending longevity, Aag activity in Atm
-/-
 mice actually decreases longevity. This 
counter-intuitive finding is considered further in the discussion. 
 
We also monitored disease incidence and tumor spectrum in the aged Atm
-/-
, Mgmt
-/-
/Atm
-/-
 or  
Aag
-/-
/Atm
-/-
 mice; Figure 2B shows the incidence of spontaneous pathology.  WT, Mgmt
-/-
 and 
Aag
-/-
 mice exhibit a remarkably similar spectrum of tumors, but this spectrum is significantly 
different from that in the Atm deficient genotypes (Atm
-/-
, Mgmt
-/-
/Atm
-/-
, and Aag
-/-
/Atm
-/-
) that 
exhibit a predominance of lymphoma [56, 58]; 94% of the Atm
-/-
 mice in our study presented 
with lymphomas at the time of death.  Aag
-/-
/Atm
-/-
 animals exhibit a decreased incidence of 
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lymphoma (70%), and the overall difference in tumor spectrum between Atm
-/-
 and Aag
-/-
/Atm
-/- 
mice is statistically significant (p<0.016).  This suggests that one mechanism by which Aag 
deficiency increases longevity in Atm
-/-
 animals may be by decreasing the development of 
aggressive lymphomas.  Although Mgmt
-/-
/Atm
-/-  
also display a decrease in lymphoma incidence 
(71.5%), it did not alter the overall tumor spectrum (p=0.19) (Figure 2B) or longevity (Figure 
1B), suggesting that the tumors that arose instead of lymphoma in Mgmt
-/-
/Atm
-/-  
 mice  were as 
aggressive as lymphoma. 
 
Detailed survival studies have been published for p53
-/-
 mice [57], and here we set out to 
determine whether decreased repair of primarily alkylated DNA bases would affect longevity in 
p53
-/-
 mice.   In stark contrast to the effect of combining Aag
-/-
 or Mgmt
-/-
 with the Atm
-/-
 
genotype, we observe virtually identical survival in p53
-/-
, Aag
-/-
/p53
-/-
, and Mgmt
-/-
/p53
-/-
 mice; 
all three genotypes exhibited significant and similarly-decreased survival compared to WT mice 
(p<0.0001) (Figure 3A).  All p53 deficient genotypes exhibited an altered tumor spectrum 
compared to WT mice, but there was no difference in tumor spectrum between p53
-/-
, Aag
-/-
/p53
-
/-
, and Mgmt
-/-
/p53
-/-
 mice (Figure 3B).   
 
2.3  Genetic interaction between Mgmt and the MMR pathway 
 
Given the established link between Mgmt and MMR in modulating alkylation-induced 
cytotoxicity [37, 40, 41, 59, 60], we investigated whether deficiency of both Mgmt and MMR 
proteins may cooperate to alter longevity.   The effect of eliminating mismatch recognition and 
excisions steps of MMR in combination with Mgmt was investigated.  As described, Mgmt 
deficiency does not significantly alter long-term survival in vivo (Figure 1A).  Figure 4A 
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presents survival data for WT, Mgmt
-/-
, Msh6
-/-
, Exo1
-/-
, Mgmt
-/-
/Msh6
-/-
 and Mgmt
-/-
/Exo1
-/- 
mice.  
Similar to previous reports, we observe significantly decreased survival in Msh6
-/-
 and Exo1
-/-
 
mice compared to WT mice (p<0.0001) [61, 62].  We observed a trend toward increased 
longevity in Mgmt
-/-
/Msh6
-/-
, which did not reach statistical significance (pairwise comparison 
between Msh6
-/-
and Mgmt
-/- 
Msh6
-/-
, p<0.3388).  Similarly, the trend toward increased survival in 
Mgmt
-/-
/Exo1
-/- 
versus Exo1
-/- 
mice did not reach statistical significance (pairwise comparison 
between Exo1
-/-
and Mgmt
-/-
 Exo1
-/-
, p=0.1352) (Figure 4A).  We infer that Mgmt substrates do 
not significantly impact whole-animal survival, even in the absence of functional MMR.  
Although a genetic interaction was observed between Mgmt and Msh6 or Exo1 in terms of 
mediating alkylation cytotoxicity upon treatment with exogenous alkylating agents in vivo [63], 
this does not appear to translate to effects from endogenous alkylation arising in vivo.   
 
Detailed histological examination of the aged animals showed that the trends toward increased 
survival were accompanied by differences in pathology.  Figure 4B shows the incidence of 
spontaneous pathology in animals with combinations of the Mgmt null allele with either Msh6 or 
Exo1 null alleles, namely Mgmt
-/-
, Msh6
-/-
, Exo1
-/-
, Mgmt
-/-
/Msh6
-/-
, and Mgmt
-/-
/Exo1
-/- 
mice.  The 
majority of the MMR defective animals exhibit lymphomas at the time of death; 70% of Msh6
-/- 
animals and 70.5% of Exo1
-/-
 animals present with lymphoma, consistent with the published 
literature (Figure 4B) [61, 62].  The additional inactivation of the Mgmt gene does not 
significantly alter the tumor spectrum in Msh6 mutant background; 73% of Mgmt
-/-
/Msh6
-/- 
mice 
develop lymphoma (Figure 4B).  Remarkably, Mgmt deficiency results in a greater than 50% 
reduction in the incidence of lymphoma in Exo1
-/-
 mice; 70.5% in Exo1
-/- 
mice develop 
lymphoma whereas only 31% of Mgmt
-/- 
/Exo1
-/-
 mice present with this pathology.  The reduction 
of lymphoma in Mgmt
-/- 
/Exo1
-/-
 mice coincides with a two-fold increase in histiocytic sarcoma, 
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the predominant pathology observed in Mgmt
-/-
 mice.  The change in tumor spectrum between 
the Exo1
-/- 
and the Mgmt
-/-
/Exo1
-/-
 is significant (p=0.03).   
 
2.4  The contribution of Atm to cellular responses following exogenous DNA alkylation 
damage  
Aag deficiency resulted in a counter-intuitive increase in longevity in Atm
-/- 
deficient mice, 
accompanied by alterations in the tumor spectrum (Figures 2A and 2B).  To further examine this 
genetic interaction between Atm and Aag, we used the tractable bone marrow (BM) ex vivo 
clonogenic survival assay to determine whether, as seems to be the case for endogenous DNA 
damage, Atm modulates Aag-mediated alkylation-induced cytotoxicity.    BM cells were treated 
ex vivo with the alkylating agent methyl methane sulfonate (MMS) and then plated on semisolid 
media to allow formation of hematopoietic myeloid progenitor colonies.  MMS is an SN2 
alkylating agent that induces predominantly 7MeG and 3MeA DNA lesions, known Aag 
substrates [34].  Consistent with a previous report [64], we show here that Aag
-/-
 BM cells are 
resistant to MMS (Figure 5).  This is consistent with multiple recent reports showing that  
initiation of BER by DNA glycosylases generates repair intermediates (AP-sites, and single-
strand breaks (SSBs)) that, if accumulate due to downstream BER enzymes being limited, are 
more toxic than the original DNA base lesions (reviewed in [33]).  This is supported by evidence 
indicating that alkylation sensitivity is dependent on Aag-initiated BER both in cultured cells and 
in animals [65-67].   Interestingly, Atm
-/- 
BM cells display increased MMS sensitivity in 
comparison to all other genotypes, indicating that Atm signaling is an important mediator of 
MMS-mediated toxicity.  The increased sensitivity observed in Atm
-/- 
BM cells is almost totally 
suppressed in Aag
-/-
/Atm
-/-
 BM cells, suggesting that much of the alkylation sensitivity observed 
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in the Atm
-/-
 cells is due to Aag-initiated BER of MMS-induced base damage followed by the 
accumulation of toxic BER intermediates that are ultimately sensed by Atm (Figure 5A).  
Together, these ex vivo assays illustrate that Atm is an integral modulator of toxicity induced by 
Aag-initiated BER, and pinpoints a role for the Atm DNA damage response protein in signaling 
downstream of toxic BER intermediates. 
 
We also assessed the contribution of Atm to O
6
meG-mediated cytotoxicity following exposure to 
the SN1 alkylating agent, N-methyl-N-nitrosourea (MNU), which generates toxic and mutagenic 
O
6
MeG, in addition to 7meG and 3meA DNA base lesions.  Ex vivo clonogenic survival assays 
were performed with BM from WT, Mgmt
-/-
, Atm
-/-
 and Mgmt
-/-
/Atm
-/-
mice.  In contrast to MMS, 
Atm
-/-
 BM cells exhibit no difference in MNU sensitivity compared to WT cells at the doses used 
(Figure 5B), presumably because both WT and Atm
-/-
 cells express Mgmt to reverse the toxic 
 O
6
meG lesions.  Accordingly, Mgmt
-/-
 cells exhibit increased sensitivity to MNU compared to 
both WT and Atm
-/-
 cells.  Strikingly, we observe a massively synergistic interaction between 
Mgmt and Atm; Mgmt
-/-
/Atm
-/-
 cells exhibit dramatically increased sensitivity to MNU when 
compared to Mgmt
-/-
 or Atm
-/-
 cells (Figure 5B).  We infer that when O
6
MeG base lesions are 
unrepaired (as in the Mgmt
-/-
 cells), Atm plays a pivotal role in modulating the toxicity induced 
by MMR processing of DNA containing O
6
MeG DNA lesions.   
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3  DISCUSSION 
 
Here we describe a large-scale aging study of numerous mouse models defective in several DNA 
repair genes and DNA damage response genes (Supplemental Table 1).  Essential for a study of 
this magnitude, all animals were backcrossed to the C57Bl/6 genetic background for at least 10 
generations to ensure that any differences observed could not be attributed to differences in strain 
background.    
 
Accumulating toxic and mutagenic damage in mitochondrial and nuclear DNA is known to 
affect the aging process in model organisms [68-71].  We show here that endogenously damaged 
DNA bases that are substrates for two DNA alkylation repair pathways contribute to long-term 
survival; mice deficient in both Aag and Mgmt activity exhibit decreased life-span that is 
statistically significant.  The accumulation of unrepaired DNA damage and mutations associated 
with aging may simply arise due to long-term exposure to endogenous metabolites that damage 
DNA, and may be exacerbated by an age-related decline in the DNA repair capacity.  The 
capacity to perform BER, NER and double-strand break (DSB) repair have, in fact, all been 
shown to decline with age (reviewed in [72-74]).  Further, studies in mice indicate that certain 
tissues or anatomical sites may be more susceptible to such age-related DNA repair decline [69] 
perhaps due to differing exposure to RONS [75, 76].  All of these possibilities are not necessarily 
mutually exclusive and likely cooperate as contributing factors in influencing longevity.  Indeed, 
in the worst case scenario, aging tissues could have both decreased DNA repair and DNA 
damage responses accompanied by increased levels of endogenous metabolites that damage 
DNA. 
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We and others have demonstrated that for certain cell types Aag-mediated initiation of BER can 
lead to cell death, and that Aag deficiency can actually be protective [65, 66].  Here, we find that 
Aag deficiency protects Atm
-/-
 mice both in terms of increasing overall longevity and in reducing 
the development of lymphoma; this protection is consistent with a role for Aag in generating 
toxic BER intermediates that trigger the DNA damage response orchestrated by Atm.  Further, 
Aag deficiency provided protection against MMS-induced toxicity in Atm
-/-
 BM cells, ex vivo.  
Together, this indicates that Atm is required for protection against Aag-mediated alkylation-
induced toxicity, and that endogenously-generated Aag substrates can influence organismal 
longevity.  This may not be surprising given that Aag acts on a wide range of endogenously-
generated base lesions including 7meG, 3meA, deaminated adenine, oxidized guanine and 
etheno-base lesions [26, 34, 77, 78].    A link between Atm and BER has been implicated in 
numerous reports [79-81], but the data here provide in vivo evidence that Atm plays a key role in 
protecting against the detrimental effects of Aag-mediated BER intermediate formation at sites 
of spontaneous DNA base damage.  
 
Interestingly, although ATM is known to phosphorylate, stabilize and activate p53 [82], there is 
no change in survival in  Aag
-/-
/p53
-/-
 mice, in contrast to enhanced survival in Aag
-/-
/Atm
-/-
 mice.  
The protection in Aag
-/-
/Atm
-/-
 mice compared to Aag
-/-
/p53
-/-
 mice may be explained by the 
numerous p53-independent functions of Atm [82].  Alternatively, it has been shown previously 
that Aag physically interacts with and represses p53 [83]; therefore genetic deletion of both Aag 
and p53 would be epistatic and not alter overall survival compared to p53
-/-
 mice.   
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Mgmt deficiency does not affect survival or tumor spectrum in Atm
-/-
 mice.  However, a clear 
genetic interaction between Mgmt and Atm was observed in the ex vivo BM clonogenic survival 
assays.  Predictably, Mgmt
-/- 
BM cells exhibit alkylation hypersensitivity but surprisingly, Mgmt
-
/- 
/Atm
-/-
 BM cells exhibit a synergistic increase in alkylation sensitivity.  We propose that in the 
absence of Mgmt, futile cycling of MMR at O
6
meG:T mispairs results in the generation of DSBs 
that activate Atm [83-86].  Without Atm and Mgmt, MMR-mediated futile cycling continues 
without the Atm-mediated signaling pathways, further exacerbating cell death.  Together, this 
illustrates that Atm contributes to the cellular response to O
6
meG induced by exogenous 
alkylating agents, but implies that spontaneous O
6
meG lesions are not relevant in the 
development of morbidity in Atm
-/-
/Mgmt
-/-
 mice, although it is possible that the decreased 
lifespan of Atm
-/-
 mice precludes any potential cumulative detrimental effects of endogenous 
O
6
meG lesions in Atm
-/-
/Mgmt
-/-
 mice. 
 
It is intriguing that Mgmt deficiency protected Exo1
-/-
 mice against the development of 
lymphoma; instead Mgmt
-/-
/Exo1
-/-
 mice developed histiocytic sarcoma, the prevalent disease in 
C57Bl/6 mice.  Although Mgmt
-/-
/Exo1
-/-
 mice exhibited decreased incidence of lymphoma, there 
was only a trend toward increased longevity, indicating that the protection against lymphoma and 
the overall shift in tumor spectrum did not prolong lifespan.  Mgmt
-/-
 mice develop histiocytic 
sarcoma at an average latency of 25.5 months, whereas in Mgmt
-/-
/Exo1
-/-
 mice, the onset of 
histiocytic sarcoma is significantly earlier (p=0.0035), with an average latency of 21.7 months.  
Although Mgmt deficiency altered tumor penetrance in Exo1
-/-
 mice, this was not observed in 
Msh6
-/-
 mice.  Msh6 deficiency results in a strong predisposition to lymphomagenesis, which 
occurs significantly earlier than in Exo1
-/-
 mice (p=0.0002).  The constitutive MMR deficiency 
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(CMMRD) cancer syndrome in humans substantiates the role for Msh6 in preventing 
hematological malignancies and other cancers [87-89] and reinforces the finding that Msh6 
deficiency is a strong inducer of lymphoma in mice [61].  EXO1 deficiency is not causative of 
CMMRD, but EXO1 mutations have been found in diffuse B-cell lymphoma [87].  The strong 
association between MSH6 mutations and lymphoma may explain why Mgmt deficiency was 
insufficient to change tumor spectrum in Msh6
-/-
 mice, whereas Mgmt
-/-
/Exo1
-/-
 mice exhibited a 
shift in tumor spectrum towards histiocytic sarcoma.   
 
Although the link between accumulating DNA damage and aging has been clearly established, 
the consequences of lifestyle interventions that increase longevity and their role on altering DNA 
repair capacity remain unresolved.  One proven strategy demonstrated to enhance longevity is 
calorie restriction (CR); the consequence of CR on DNA repair remains controversial.  CR has 
been shown to reduce the age-dependent decline in non-homologous end joining activity [90], 
whereas other studies show a decrease in DNA repair transcript levels following CR [91].  
Additionally, it is well-known that habitual endurance exercise improves health-span [92, 93], 
and although endurance exercise is associated with an increase in oxidative DNA damage [94], 
exercise-induced RONS are thought to induce DNA repair and other molecular systems to cope 
with increased RONS damage [95-98].   Finally, resveratrol, a polyphenol found in red wine and 
an activator of the NAD-dependent deacetylase sirtuin-1 (Sirt1), has been hypothesised to 
increase longevity.  Resveratrol increases the formation of APE/XRCC1 complex during BER 
[99], but also reduces the activity or expression of other DNA repair proteins [100, 101].  These 
few examples underscore the fact that much remains to be learned regarding the relationship 
between DNA repair and lifestyle interventions that may modulate longevity.   
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Significant progress has been made regarding the pathways and factors that modulate longevity 
[1, 102, 103], and yet many questions remain unanswered.  Several theories of aging have been 
proposed including: the mitochondrial free radical theory of aging, telomere attrition, 
mitochondrial dysfunction, and more recently, the functional decline of stem cells (aging theories 
reviewed in [104-106]).  It is likely that many of the proposed mechanisms of aging interact with 
each other to influence the longevity of an organism.  Here, using long-term lifespan studies in 
DNA repair- and DNA damage-response deficient mouse models, we establish that the repair of 
DNA base alkylation damage arising from endogenous sources is at least one contributing factor 
to longevity. 
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4  METHODS 
4.1  Mice 
The Aag
-/-
 mice [107] and Mgmt
-/-
 mice [108] have been described. Trp53
-/-
 mice (B6.129S2-
Trp53
tm1Tyj
, former name C57BL/6J-Trp53
tm1Tyj
) and Atm
-/-
 mice (129S6/SvEvTac-Atm
tm1Awb/J
) 
were purchased from The Jackson Laboratory (Bar Harbor, Maine, USA).  Exo1
-/-
 and Msh6
-/-
 
mice have been described previously [61, 62].  All mice were backcrossed at least 10 times to the 
C57BL/6 background.  Mice were fed standard diet ad libitum and housed in an AAALAC 
accredited facility. Animals were sacrificed by CO2 asphyxiation.  All animal procedures were 
approved by the MIT Committee on Animal Care. 
 
4.2  Longevity studies 
Mice were allowed to age and observed for development of disease and subject to full necropsy 
when diseased or deceased. Tissues were fixed in Bouin’s fixative, paraffin embedded, sectioned 
at 5 m and stained with haematoxylin and eosin (H&E). Tissues harvested include: brain, eyes, 
salivary gland, thymus, heart, lung, liver, kidney, spleen, intestine, reproductive organs, and 
femur.  All H&E stained slides were analyzed blind by a pathologist (R.T.B) for the cause of 
death as well as for identification of any tumors/lesions.  Examples of lesions classified as other 
include: dermatitis, cystic endometrium/uterus, emphysema, kidney disease and osteoarthritis.   
 
4.3  Bone marrow clonogenic survival assay  
BM clonogenic survival assays were performed as described in [64].  Briefly, cells were 
harvested from the femurs of mice, treated ex vivo with MMS (Sigma-Aldrich Co, St. Louis, 
MO) or MNU (Sigma-Aldrich Co, St. Louis, MO) and plated in methylcellulose-containing 
media (Stem Cell Technologies, Vancouver, BC, Canada), and plated in duplicate.  After 
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approximately 2 weeks, colonies containing > 50 cells were scored. Experiments were performed 
at least three times.  
 
4.4   Statistical analysis 
GraphPad Prism was used to generate Kaplan-Meier plots for survival and to calculate 
significance using Log-rank (Mantel-Cox) test. Fisher’s exact, programmed in R, was used to 
establish whether the differences in tumor spectra between genotypes were significant.  
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5  FIGURE LEGENDS 
 
Figure 1. DNA alkylation repair contributes to longevity. A) Survival curves of wild type 
(black lines, n=37), Aag
-/-
 (red line, n=29), Mgmt
-/-
 (blue line, n=50) and Aag
-/-
 Mgmt
-/-
 (purple 
line, n=31). Pair-wise comparisons: Aag
-/-
 to wild type, p=0.1003; Mgmt
-/-
 to wild type, 
p=0.4752; Aag
-/-
 Mgmt
-/-
 to wild type, p=0.04, all Log-rank (Mantel-Cox) test.   B) 
Histopathological classification of pathologies found in WT (n=18), Aag
-/-
 (n=24), Mgmt
-/-
 
(n=35), and Aag
-/-
 Mgmt
-/-
 (n=31) mice. 
 
Figure 2. Atm plays a role in the response to endogenous/spontaneous DNA alkylation 
damage. A) Survival curves of wild type (black lines, n=37), Atm
-/-
 (green line, n=19), Aag
-/-
 
Atm
-/-
 (green/red line, n=22) and Mgmt
-/-
 Atm
-/-
 (cyan line, n=21). All pair-wise comparisons to 
wild type, p<0.0001. Pair-wise comparison between Atm
-/-
 and Aag
-/-
 Atm
-/-
, p=0.0193, and 
between Atm
-/-
 and Mgmt
-/-
 Atm
-/-
, p=0.3423, all comparisons Log-rank (Mantel-Cox) test. B) 
Aag deficiency protects against lymphoma in Atm
-/-
 animals. Graph shows the incidence of age-
related pathologies observed in Aag and Atm genotypic combinations. Wild-type (n=18); Aag
-/-
 
(n=24); Mgmt-/- (n=35); Atm
-/-
 (n=15); Mgmt
-/-
 Atm
-/-
 (n=7); Aag
-/-
 Atm
-/-
 (n=10). 
 
Figure 3. Aag and Mgmt mutations do not affect longevity of p53 mutant animals. A) 
Survival curves of wild type (black lines, n=37), p53
-/-
 (light green line, n=21), Aag
-/-
 p53
-/-
 (light 
red line, n=42), and Mgmt
-/-
 p53
-/-
 (light blue line, n=18). All pair-wise comparisons to wild type, 
p<0.0001, Log-rank (Mantel-Cox) test. B) Aag or Mgmt deficiency does not shift tumor 
spectrum in p53
-/-
 mice.  Graph shows the incidence of age-related pathologies observed in Aag 
and p53 genotypic combinations. Wild-type (n=18); p53
-/-
 (n=8); Aag
-/-
 p53
-/-
 (n=14); Mgmt
-/-
 
p53
-/-
 (n=9). 
 
Figure 4. Interaction between Mgmt deficiency and the mismatch repair pathway. Survival 
curves of wild type (black lines, n=37), Mgmt
-/-
 (blue line, n=50), Exo1
-/-
 (purple line, n=19), 
Mgmt
-/-
 Exo1
-/-
 (dashed lilac line, n=30), Msh6
-/-
 (orange line, n=10), and Mgmt
-/-
 Msh6
-/-
  
(dashed light orange line, n=19). Pair-wise comparison between Mgmt
-/-
 and Mgmt
-/-
 Exo1
-/-
, 
p=0.0008 and between Mgmt
-/-
 and Mgmt
-/-
 Msh6
-/-
 , p<0.0001, Log-rank (Mantel-Cox) test. B) 
The Mgmt null mutation leads to a decrease in the incidence of lymphomas in Exo1
-/-
 animals but 
not in Msh6
-/-
 animals. Wild-type (n=18); Mgmt
-/-
 (n=33), Exo1
-/-
 (n=17), Msh6
-/-
 (n=10), Mgmt
-/-
 
Msh6
-/-
 (n=19), Mgmt
-/-
 Exo1
-/-
 (n=29).  
 
Figure 5.  Atm and Aag interact in response to induced alkylation damage.  A) Ex vivo 
alkylation sensitivity of BM cells to methyl methanesulfonate (MMS). BM cells were derived 
from wild type (closed squares), Aag
-/-
 (closed triangle), Atm
-/-
 (open squares) and Aag
-/-
 Atm
-/-
 
(open triangle) mice. Experiments were done a minimum of three times each, data are mean ± 
SEM..  B) Synergistic interaction between Mgmt and Atm in response to MNU treatment. Ex 
vivo alkylation sensitivity of BM cells to methyl nitrosourea (MNU). BM cells were derived 
from wild type (closed squares), Mgmt
-/-
 (closed circles), Atm
-/-
 (open squares) and Mgmt
-/-
 Atm
-/-
 
(open circles) mice. Experiments were done a minimum of three times each, data are mean ± 
SEM. 
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Table 1:  Median survival of all mice, median survival of 
mice with tumors, and tumor penetrance in aging study.  
Genotype 
Median 
Survival, 
weeks 
Median 
Survival 
(tumor), 
weeks 
% tumor at 
termination 
Wildtype 106 98 61.1 
Aag-/- 94 99 54.2 
Mgmt-/- 99.5 103.5 57.1 
Atm-/- 29 35 100 
p53-/- 20 21.5 100 
Exo1-/- 81 82.3 94.1 
Msh6-/- 26.5 25 100 
Aag-/-Mgmt-/- 89.5 94.5 58 
Aag-/-Atm-/- 44 63 90 
Aag-/-p53-/- 20 22 92.8 
Mgmt-/-Atm-/- 40 49 100 
Mgmt-/-p53-/- 20.5 22 100 
Mgmt-/-Exo1-/- 91.5 92 96.5 
Mgmt-/-Msh6-/- 45 45 100 
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